General practitioners' contribution to dependence assessment: The OPEMA programme;Observation des pharmacodépendances en médecine ambulatoire: le programme OPEMA

Therapie

Volumn 67, Issue 4, 2012, Pages 397-404

  Moracchini, Christophe ^a,b   Orleans, Veronica ^a   Miloudi, Samira ^a   Frauger, Elisabeth ^b,c   Micallef, Joëlle ^b,c   Thirion, Xavier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Drug use; Epidemiology; General practitioners; Substance related disorders

Indexed keywords

BENZODIAZEPINE DERIVATIVE; OPIATE; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; COMORBIDITY; DEMOGRAPHY; DRUG DEPENDENCE; DRUG USE; EMPLOYMENT; EMPLOYMENT STATUS; GENERAL PRACTITIONER; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ABUSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MENTAL DISEASE; PRIORITY JOURNAL; PREVALENCE; QUESTIONNAIRE;

BENZODIAZEPINES; COMORBIDITY; GENERAL PRACTITIONERS; HUMANS; PREVALENCE; SURVEYS AND QUESTIONNAIRES;

EID: 84869014311     PISSN: 00405957     EISSN: 19585578     Source Type: Journal    
DOI: 10.2515/therapie/2012037     Document Type: Article

References (11)

1. Frauger E, Nordmann S, Orleans V, et al. Which psychoactive prescription drugs are illegally obtained and through which ways of acquisition? About OPPIDUM survey. Fundam Clin Pharmacol 2011, May 12. doi: 10.1111/ j.1472-8206.2011.00950.x
2. Frauger E, Thirion X, Micallef J, et al. Le programme de surveillance OPPIDUM du Réseau des CEIPs :20 ans d'expérience déjà. Lettre du Pharmacologue 2009; 23 (4): 128-33
3. Lapeyre-Mestre M, Damase-Michel C, Adams P, et al. Falsified or forged medical prescriptions as an indicator of pharmacodependence: a pilot study. Eur J Clin Pharmacol 1997; 52(1): 37-9 (Pubitemid 27168209)
4. Boeuf O, Lapeyre-Mestre M, French Network of CEIP-A. Survey of forged prescriptions to investigate risk of psychoactive medications abuse in France: results of OSIAP survey. Drug Saf 2007; 30(3): 265-76 (Pubitemid 46425637)
5. Afssaps, CEIPs. ASOS, Résultats de l'enquête 2008 et résumé des résultats des enquêtes ASOS 2002-2007. http://www.afssaps.fr/var/afssaps-site/ storage/original/application/ cf8c0ec0196b07a8b73ef7494b38459e.pdf
6. Djezzar S, Questel F, Burin E, et al. Chemical submission: results of 4-year French inquiry. Int J Legal Med 2009 May; 123(3): 213-9
7. Boulos J, Arditti G, Pepin M, et al. DRAMES, outil d'identification des causes de décès chez les toxicomanes: résultats des études 2002-2006. Le courrier des addictions 2008; 1: 16-8
8. Conseil National de l'Ordre des Médecins. Atlas de la démographie médicale en France, Situation au 1er janvier 2011. Paris, 2011, 204 P
9. Assemblée nationale. Mission d'information sur les toxicomanies. Rapport d'information sur les toxicomanies, page 31. 30 juin 2011. http:// www.assemblee-nationale.fr/13/pdf/rap-info/i3612-ti.pdf
10. Afssaps. Compte rendu de la Commission nationale des stupéfiants et des psychotropes du 17 février 2011.
11. http://www.afssaps.fr/var/afssaps-site/storage/original/application/ b2fb75f473939d0e4f5cdf8c2c46d59f.pdf